Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches

Group B streptococcus (Streptococcus agalactiae, GBS) is an important cause of life-threatening disease in newborns. Pregnant women colonized with GBS can transmit the bacteria to the developing fetus, as well as to their neonates during or after delivery where infection can lead to sepsis, meningit...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Judith Absalon, Raphael Simon, David Radley, Peter C. Giardina, Kenneth Koury, Kathrin U. Jansen, Annaliesa S. Anderson
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2022-01-01
Edice:	Human Vaccines & Immunotherapeutics
Témata:	gbs;invasive disease;infants;iap;capsular polysaccharide;conjugate vaccine;maternal immunization;serocorrelate
On-line přístup:	http://dx.doi.org/10.1080/21645515.2022.2037350
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!